Medpace 

€306.1
115
-€0.9-0.29% Hari ini

Statistik

Harga Tertinggi Hari Ini
306.1
Harga Terendah Hari Ini
306.1
52M Tinggi
-
52M Rendah
-
Volume
0
Rata-Rata Volume
-
Kap Pasar
9.38B
Rasio P/E
31.54
Hasil Dividen
-
Dividen
-

Mendatang

Pendapatan

21OctDiharapkan
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Berikutnya
2.31
2.54
2.77
3
EPS yang Diharapkan
2.5254798961800002
EPS Aktual
T/A

Orang Juga Mengikuti

Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti 01P.F. Ini bukan rekomendasi investasi.

Peserta

Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.

Tentang

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Karyawan
5800
Negara
US
ISIN
US58506Q1094
WKN
000A2APTV

Daftar